Pharmafile Logo
Pharmafocus logo
Advanced Search

Latest Feature Articles

falsified_medicines

Counterfeit drugs – countering the lies

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Counterfeit drugs, IP, counterfeit medicines, falsified medicines, intellectual property, law, legal, patent

As the Falsified Medicines Directive comes into effect in February 2019, Louis Goss fact checks ‘common sense’ claims on counterfeit …

Feature
both_together

Repurposed drugs: The Supreme Court deals a blow to patentees

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Supreme Court, drug repurposing, feature, patents, pharma

Second medical use patents protect the discovery that an existing drug is effective to treat a new condition. But, following …

Feature
mesothelioma

Pushing for progress in mesothelioma

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Cancer, mesothelioma, pharma

Mesothelioma.net reviews the wide array of latest advances in treatment and care for patients affected by the challenging cancer as …

Feature
nve00002_web

Living with Alström syndrome

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Alström syndrome, patient experience, pharma, rare disease

Kay Parkinson lived the tragedy of seeing both of her children born with an ultra-rare condition, and the elusiveness of …

Feature

How tech is powering precision treatment

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | AI, Precision Medicine, pharma, tech

As the scientific community eschews scattergun approaches and demand rises for higher-quality, targeted care, Matt Fellows explores how technologies such …

Feature
82958bfc7df1311fd17a008495fc-1456375

Pharma in 2018: Looking back, looking forward

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | 2018, Alligator Bioscience, Eisai, Gilead, Mundipharma, pharma

2018 has been a year characterised by uncertainty, but also significant leaps in research, access, and industry deals. With 2019 …

Feature
maps-2018-01-boulder-staged-lana-marcela-bruce-bryce-img_20180128_135008_preview

Psychedelic therapy: A new approach to mental health

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | LSD, MDMA, controlled substances, depression, mental health, pharma, psychotherapy

In November 2018, a Phase 2 clinical trial found that 76% of patients who underwent MDMA-assisted psychotherapy no longer had …

Feature

Working Life: Kai Gait, Senior Global Digital Director at GlaxoSmithKline

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | EU, GSK, Interview, UK, US, digital, senior global director, technology

Kai Gait, Senior Global Digital Director at GlaxoSmithKline, retraces the steps that have led him to where he is today, …

Feature

Insider Interview: The diabetes/mental health connection

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Insider Interview, Type 1 diabetes, World Diabetes Day, diabetes, feature, mental health, pharma

Michael Connellan, Head of External Affairs at the type 1 diabetes charity JDRF, discusses the results of a recent survey …

Feature
psm_v46_d168_mesial_view_of_the_human_brain

Rising to the challenge of delivering therapeutic discovery for mental disorders

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | NIHRm, Oxford, R&D, feature, investment, mental health

Professor Matthew Hotopf, Director of NIHR Maudsley Biomedical Research Centre, and Professor John R Geddes, Director of NIHR Oxford Health …

Feature

Working Life: Philippe Bastide, Head of Biosimilars, Mundipharma

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Cancer, Mundipharma, Philippe Bastide, biosimilars, leukaemia

“Don’t conform to what people want – take risks. The people who make a big difference are the ones who …

Feature
helena-baker

Living with fibular hemimelia

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | cambridge rare disease network, diagnosis, fibular hemimelia, rare disease, therapy

Helena Baker, Vice President of Clinical Strategy at Medical Research Network and a trustee of the newly formed Rare Disease …

Feature
horrible_monster_vaccination

Anti-vaxxers: Vaccines in the age of populism

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | anti vaccine, anti-vaccine, history, medicine, populism, vaccines

Mistrust of the establishment has fuelled anti-vaccine sentiment in recent years, and adherence has waned as a result. Louis Goss …

Feature

Galectin-3: The protein paving new treatment avenues

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Galectin-3, Galectins, breast cancer, diabetes, heart disease, pharma

Matthew Blakeley, LADI-III Beamline Scientist at Institut Laue-Langevin (ILL) and Derek Logan, Associate Professor in Structural Biology at Lund University, …

Feature
shutterstock_243110086

Not so crystal clear: The EU’s clinical reporting problem

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | EBM Datalabs, clinical trial transparency, clinical trials, feature, pharma, transparency

With shocking new findings revealing that around half of all clinical trial results in Europe go unreported, Matt Fellows explores …

Feature
Load more Feature Articles
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025